SC 13D

Company

MADRIGAL PHARMACEUTICALS, INC.

Filed

June 20, 2023

Accession Number

0001104659-23-072412

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →